Swedbank’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,300
Closed -$4.15M 701
2025
Q4
$4.15M Buy
+25,300
New +$3.96M ﹤0.01% 586
2025
Q2
Sell
-30,000
Closed -$3.82M 695
2025
Q1
$3.82M Hold
30,000
0.01% 568
2024
Q4
$4.32M Sell
30,000
-20
-0.1% -$2.87K 0.01% 566
2024
Q3
$4.47M Buy
30,020
+20
+0.1% +$2.87K 0.01% 558
2024
Q2
$3.78M Hold
30,000
0.01% 565
2024
Q1
$5.52M Sell
30,000
-10,000
-25% -$1.9M 0.05% 386
2023
Q4
$7.19M Sell
40,000
-10,000
-20% -$1.56M 0.01% 482
2023
Q3
$7.95M Buy
+50,000
New +$8.17M 0.01% 449
2022
Q3
Sell
-10,000
Closed -$1.62M 757
2022
Q2
$1.62M Buy
+10,000
New +$1.58M ﹤0.01% 613

Other funds holding RGEN

Swedbank's RGEN Position: Q1 2026 in Review

Swedbank sold out of Repligen (RGEN) in Q1 2026, closing a stake of 25,300 shares — an estimated $4.15M sold.

Swedbank first reported a position in RGEN in Q2 2022 and held it in 9 quarters. The position peaked at $7.95M in Q3 2023. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Swedbank reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Swedbank sold 25,300 Repligen shares in Q1 2026, an estimated $4.15M.
  • Swedbank first reported a position in Repligen in Q2 2022 and held it in 9 quarters.
  • Swedbank's Repligen position peaked at $7.95M in Q3 2023.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Swedbank's 13F filing for Q1 2026, filed 29 Apr 2026.